Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $42.71, with a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has granted Cour Pharmaceuticals orphan drug ...

Scout Investments, Inc., an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the ...

CenterPoint Energy (CNP) is a Buy: 7–9% earnings growth to 2035, $65.6B capex plan, improving metrics, and dividend growth. See more details here.

CenterPoint Energy Inc (CNP) reports robust financial performance with 9% EPS growth and unveils a $500 million increase in its capital investment plan, signaling confidence in sustained growth.

CenterPoint Energy, Inc.'s ( NYSE:CNP ) dividend will be increasing from last year's payment of the same period ...

A Prescription Drug User Fee Act target date of November 30, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application ...

CenterPoint Energy CNP benefits from rising electricity consumption, driven by the rapid electrification of transportation and buildings, along with increasing investments in renewable energy. Given ...